74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Hologic Inc
Open
SectorHealthcare
60.92 0.36
Overview
Share price change
24h
Min
59.01
Max
61.11
Income | 201M |
|---|---|
Sales | 34M 1B |
P/E Sector Avg | 19.548 63.778 |
EPS | 1.03 |
Profit margin | 19.671 |
Employees | 7,063 |
EBITDA | 51M 352M |
Recommendations | Neutral |
|---|---|
12 Months Forecast | +35.63% upside |
Next Earnings | 1 May 2025 |
|---|
Market Cap | -3B 14B |
|---|---|
Previous open | 60.56 |
Previous close | 60.92 |
News Sentiment
By Acuity
22%
78%
55 / 386 Healthcare
Technical Score
By Trading Central
Confidence
Weak Bearish Evidence
Hologic Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Hologic Inc Forecast
Price Target
By TipRanks
35.63% upside
12 Months Forecast
Average 83.25 USD 35.63%
High 90 USD
Low 70 USD
Based on 12 Wall Street analysts offering 12 month price targets forHologic Inc - Dist in the last 3 months.
Sentiment
By Acuity
55 / 386 Healthcare
News Sentiment
Very Strong Bullish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Hologic Inc
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, and specimen radiology solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. The company was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.
